Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Dec 18, 2013
Insider Transaction Report
Form 4
Seaman Scott B
Director
Transactions
- Purchase
Common Stock
2013-12-18$1.70/sh+30,000$51,000→ 40,913 total
Holdings
- 518,708(indirect: See footnote.)
Common Stock
Footnotes (2)
- [F1]Purchased in an underwritten public offering which is expected to close on December 23, 2013.
- [F2]Held by Alkek & Williams Ventures, Ltd. ("Ventures"). Chaswil, Ltd. ("Chaswil") is the investment manager of Ventures and holds voting power and investment power with respect to the Issuer securities held by Ventures. Mr. Seaman is a registered principal of Chaswil and has shared voting power and/or investment power with respect to the Issuer securities held by Ventures. Mr. Seaman disclaims beneficial ownership of the shares held by Ventures except to the extent of any pecuniary interest therein.